That’s a very good question, but I think it’s a question for which we would love to have a definitive answer. I don’t think we have yet. Of course, this is my own personal view, but we have three trials that didn’t show a benefit of thrombectomy, and we have one trial from China, but from a different population, that did show a benefit. Again, clinical decisions need to be made individualized for patients...
That’s a very good question, but I think it’s a question for which we would love to have a definitive answer. I don’t think we have yet. Of course, this is my own personal view, but we have three trials that didn’t show a benefit of thrombectomy, and we have one trial from China, but from a different population, that did show a benefit. Again, clinical decisions need to be made individualized for patients. But I think what we observed after the publication of these trials is that maybe the equipoise has become larger. Maybe before these trials, people were more convinced of the benefit of thrombectomy in this group. And maybe now there’s more space to actually randomize patients who actually might benefit from thrombectomy so that we can get a definitive answer. So though it’s not a clinically actionable recommendation, I think what we do need is still to get more precision either by combining the data of these established trials and or by conducting additional trials on this topic because I think we are still not there yet in terms of having clear evidence of which patients should be treated or not.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.